In addition, SRP9 has shown potential as a prognostic marker for colorectal cancer and non-Hodgkin’s lymphoma (Lee et al., 2017; Matsumoto et al., 2021). This evidence concerns the gene SRP9 and non-Hodgkin lymphoma.